I emailed my questions re Kempfield to Argent's contact email address last weekend. The questions were about the DFS strategy, possible impact of deep drill results on DFS scope, funding/CR, native title status and timeframe for earning 70% of Kempfield. I said I didn't expect an immediate response but if they could address them at the next boardroom radio interview that would be fine.
Received an unexpected phone call this afternoon from Kerry McHugh. He had some trouble reaching my email address but wanted to say he has taken my questions on board and will endeavour to answer them via brr after the results of the reviewed Kempfield scoping study are released in 2 - 3 weeks time. I asked him about what silver price he would use in the study given the recent upwards movement, he is planning to use the current price and also apply a sensitivity range analysis to that.
He also confirmed Bullant remains on track with no unexpected problems at this point.
- Forums
- ASX - By Stock
- kempfield dfs & strategy?
ARD
argent minerals limited
Add to My Watchlist
4.76%
!
2.2¢

I emailed my questions re Kempfield to Argent's contact email...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $31.81M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $118.9K | 5.402M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3581053 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1844464 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 3509053 | 0.021 |
10 | 2973500 | 0.020 |
11 | 1934131 | 0.019 |
7 | 2985825 | 0.018 |
5 | 1272341 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 1720023 | 4 |
0.024 | 2890592 | 8 |
0.025 | 2272700 | 4 |
0.026 | 872300 | 5 |
0.027 | 2900071 | 10 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
ARD (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online